Yann Wallez

3PUBLICATIONS
38CO-AUTHORS
Biomolecular modelling and designMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 10, 2022
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305.

Krista Kinneer, Philipp Wortmann, Zachary A Cooper

|Jan 26, 2022
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib.

Zena Wilson, Rajesh Odedra, Yann Wallez

|Jun 13, 2018
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression.

Yann Wallez, Charles R Dunlop, Timothy Isaac Johnson

Pageof 1

Frequent Collaborators

1 joint publications

Charles R Dunlop

1 joint publications

Siang-Boon Koh

1 joint publications

Frances M Richards

1 joint publications

Adina M Hughes